NCT06805747

Brief Summary

The purpose of this clinical trial is to investigate the effects of laparoscopic surgery in the Trendelenburg and Reverse Trendelenburg positions, and variable tidal volume ventilation (V-VCV), pressure-regulated volume-controlled ventilation (PRVC), conventional volume-controlled ventilation (C-VCV), and pressure-controlled ventilation (PCV) on esophageal pressure, airway pressure, tidal volume, intracranial pressure, and cerebral blood flow. The study aims to address the following primary questions:Does laparoscopic surgery in the Trendelenburg or Reverse Trendelenburg position increase esophageal pressure, airway pressure, and intracranial pressure, and decrease tidal volume and cerebral blood flow? Do variable tidal volume ventilation (V-VCV), pressure-regulated volume-controlled ventilation (PRVC), conventional volume-controlled ventilation (C-VCV), or pressure-controlled ventilation (PCV) increase esophageal pressure, airway pressure, and intracranial pressure, and decrease tidal volume and cerebral blood flow? The investigators will compare variable tidal volume ventilation (V-VCV), pressure-regulated volume-controlled ventilation (PRVC), conventional volume-controlled ventilation (C-VCV), and pressure-controlled ventilation (PCV) to determine which ventilation mode results in the least physiological disturbance for patients. Participant Procedures: Participants will: Be positioned according to the surgical requirements.Be randomly assigned to mechanical ventilation with either variable tidal volume ventilation (V-VCV), pressure-regulated volume-controlled ventilation (PRVC), conventional volume-controlled ventilation (C-VCV), or pressure-controlled ventilation (PCV). Undergo assessments at the following time points: immediately after endotracheal intubation, immediately after pneumoperitoneum, immediately after position change (Trendelenburg or Reverse Trendelenburg), 30 minutes after position change, and 1 hour after position change. Have their esophageal pressure, airway pressure, intracranial pressure, tidal volume, and internal jugular vein blood flow recorded at each assessment time point.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 19, 2025

Completed
13 days until next milestone

Study Start

First participant enrolled

February 1, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 3, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2025

Completed
Last Updated

February 3, 2025

Status Verified

January 1, 2025

Enrollment Period

3 months

First QC Date

January 19, 2025

Last Update Submit

January 28, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • esophageal pressure

    immediately after tracheal intubation

  • airway pressure

    immediately after tracheal intubation

  • intracranial pressure

    immediately after pneumoperitoneum

  • tidal volume

    immediately after tracheal intubation

  • carotid blood flow

    half an hour after change of position

Study Arms (8)

T-V-VCV Group

EXPERIMENTAL

Variable tidal volume ventilation (V-VCV) :The initial tidal volume was set at 6-8 ml/kg IBW according to the Ideal Body Weight (IBW).The maximum tidal volume (Vt\_max) and minimum tidal volume (Vt\_min) were set at 10-20% of the basal tidal volume (Vt\_base). Respiratory Rate 12. Inspiratory Flow Rate (IFR) 60L/min, Inspiratory to Expiratory Ratio (IER) 1:2, Positive End-Expiratory Pressure (PEEP) 5cm water column, and Inhaled Oxygen Concentration (FiO2) 41%. Use of the trendelenburg position:Lower the head of the bed by 30 degrees with no more than 15 degrees of lateral tilt.

Other: Variable tidal volume ventilation (V-VCV)Other: Trendelenburg position

T-PRVC Group

EXPERIMENTAL

Pressure-regulated volume-controlled ventilation (PRVC) :The initial tidal volume was set at 6-8 ml/kg IBW according to the Ideal Body Weight (IBW), the upper limit of peak inspiratory pressure was 30 cmH2O, the maximum tidal volume (Vt\_max) and the minimum tidal volume (Vt\_min) was set at 10-20% of the base tidal volume (Vt\_base). Respiratory Rate is 12, Inspiration to Expiration Ratio is 1:2, Positive End-Expiratory Pressure (PEEP) is 5cmH2O, and Inhaled Oxygen Concentration (FiO2) is 98%. Use of the trendelenburg position:Lower the head of the bed by 30 degrees with no more than 15 degrees of lateral tilt.

Other: Pressure-regulated volume-controlled ventilation (PRVC)Other: Trendelenburg position

T-C-VCV Group

EXPERIMENTAL

Conventional volume-controlled ventilation (C-VCV)The initial tidal volume was set at 6-8 ml/kg IBW according to the Ideal Body Weight (IBW).The maximum tidal volume (Vt\_max) and minimum tidal volume (Vt\_min) were set at 10-20% of the basal tidal volume (Vt\_base). Respiratory Rate 12.Inspiratory Flow Rate (IFR) 60L/min, Inspiratory to Expiratory Ratio (IER) 1:2, Positive End-Expiratory Pressure (PEEP) 5cm water column, and Inhaled Oxygen Concentration (FiO2) 98%. Use of the trendelenburg position:Lower the head of the bed by 30 degrees with no more than 15 degrees of lateral tilt.

Other: Conventional volume-controlled ventilation (C-VCV)Other: Trendelenburg position

T-PVC Group

EXPERIMENTAL

Pressure-controlled ventilation (PCV):The inspiratory pressure level is set, usually with an initial value of 20 cmH2O, a respiratory rate of 12, an inspiratory/expiratory ratio of 1:2, a positive end-expiratory pressure (PEEP) of 5 cm water column, and an inspired oxygen concentration (FiO2) of 98%. Use of the trendelenburg position:Lower the head of the bed by 30 degrees with no more than 15 degrees of lateral tilt.

Other: Pressure-controlled ventilation (PCV)Other: Trendelenburg position

R-V-VCV Group

EXPERIMENTAL

Variable tidal volume ventilation (V-VCV) :The initial tidal volume was set at 6-8 ml/kg IBW according to the Ideal Body Weight (IBW).The maximum tidal volume (Vt\_max) and minimum tidal volume (Vt\_min) were set at 10-20% of the basal tidal volume (Vt\_base). Respiratory Rate 12. Inspiratory Flow Rate (IFR) 60L/min, Inspiratory to Expiratory Ratio (IER) 1:2, Positive End-Expiratory Pressure (PEEP) 5cm water column, and Inhaled Oxygen Concentration (FiO2) 41%. Use of the reverse trendelenburg position:Elevate the head of the bed by 30 degrees with no more than 15 degrees of lateral tilt.

Other: Variable tidal volume ventilation (V-VCV)Other: Reverse Trendelenburg position

R-PRVC Group

EXPERIMENTAL

Pressure-regulated volume-controlled ventilation (PRVC) :The initial tidal volume was set at 6-8 ml/kg IBW according to the Ideal Body Weight (IBW), the upper limit of peak inspiratory pressure was 30 cmH2O, the maximum tidal volume (Vt\_max) and the minimum tidal volume (Vt\_min) was set at 10-20% of the base tidal volume (Vt\_base). Respiratory Rate is 12, Inspiration to Expiration Ratio is 1:2, Positive End-Expiratory Pressure (PEEP) is 5cmH2O, and Inhaled Oxygen Concentration (FiO2) is 98%. Use of the reverse trendelenburg position:Elevate the head of the bed by 30 degrees with no more than 15 degrees of lateral tilt.

Other: Pressure-regulated volume-controlled ventilation (PRVC)Other: Reverse Trendelenburg position

R-C-VCV Group

EXPERIMENTAL

Conventional volume-controlled ventilation (C-VCV)The initial tidal volume was set at 6-8 ml/kg IBW according to the Ideal Body Weight (IBW).The maximum tidal volume (Vt\_max) and minimum tidal volume (Vt\_min) were set at 10-20% of the basal tidal volume (Vt\_base). Respiratory Rate 12.Inspiratory Flow Rate (IFR) 60L/min, Inspiratory to Expiratory Ratio (IER) 1:2, Positive End-Expiratory Pressure (PEEP) 5cm water column, and Inhaled Oxygen Concentration (FiO2) 98%. Use of the reverse trendelenburg position:Elevate the head of the bed by 30 degrees with no more than 15 degrees of lateral tilt.

Other: Conventional volume-controlled ventilation (C-VCV)Other: Reverse Trendelenburg position

R-PVC Group

EXPERIMENTAL

Pressure-controlled ventilation (PCV):The inspiratory pressure level is set, usually with an initial value of 20 cmH2O, a respiratory rate of 12, an inspiratory/expiratory ratio of 1:2, a positive end-expiratory pressure (PEEP) of 5 cm water column, and an inspired oxygen concentration (FiO2) of 98%. Use of the reverse trendelenburg position:Elevate the head of the bed by 30 degrees with no more than 15 degrees of lateral tilt.

Other: Pressure-controlled ventilation (PCV)Other: Reverse Trendelenburg position

Interventions

Variable tidal volume ventilation (V-VCV) :The initial tidal volume is set at 6-8 ml/kg IBW according to the Ideal Body Weight (IBW), and the maximum tidal volume (Vt\_max) and minimum tidal volume (Vt\_min) are set at 10-20% of the base tidal volume (Vt\_base). Respiratory Rate 12. Inspiratory Flow Rate (IFR) 60L/min, Inspiration to Expiration Ratio (IER) 1:2, Positive End-Expiratory Pressure (PEEP) 5 cm water column, and Inhaled Oxygen Concentration (FiO2) 41%.

R-V-VCV GroupT-V-VCV Group

Pressure-regulated volume-controlled ventilation (PRVC) :Initial tidal volume is set at 6-8 ml/kg IBW based on Ideal Body Weight (IBW), peak inspiratory pressure is capped at 30 cmH2O, maximum tidal volume (Vt\_max), and minimum tidal volume (Vt\_min) is set at 10-20% of basal tidal volume (Vt\_base). Respiratory Rate (RR) 12, Inspiratory Breathing Ratio (IBR) 1:2, Positive End-Expiratory Pressure (PEEP) 5 cm water column, and Inhaled Oxygen Concentration (FiO2) 98%.

R-PRVC GroupT-PRVC Group

Conventional volume-controlled ventilation (C-VCV) :The initial tidal volume is set at 6-8 ml/kg IBW based on Ideal Body Weight (IBW), and the maximum tidal volume (Vt\_max) and minimum tidal volume (Vt\_min) are set at 10-20% of the basal tidal volume (Vt\_base). Respiratory Rate 12. Inspiratory Flow Rate (IFR) 60L/min, Inspiration to Expiration Ratio (IER) 1:2, Positive End-Expiratory Pressure (PEEP) 5cm water column, FiO2 98%.

R-C-VCV GroupT-C-VCV Group

Pressure-controlled ventilation (PCV):Set inspiratory pressure level, usually 20 cmH2O initial value, Respiratory Rate 12, Inspiratory to Expiratory Ratio 1:2, Positive End-Expiratory Pressure (PEEP) 5 cm water column, Inhaled Oxygen Concentration (FiO2) 98%.

R-PVC GroupT-PVC Group

Trendelenburg position:Lower the head of the bed by 30 degrees with no more than 15 degrees of lateral tilt.

T-C-VCV GroupT-PRVC GroupT-PVC GroupT-V-VCV Group

Reverse Trendelenburg position:Elevate the head of the bed by 30 degrees with no more than 15 degrees of lateral tilt.

R-C-VCV GroupR-PRVC GroupR-PVC GroupR-V-VCV Group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age: Unrestricted
  • American Society of Anesthesiologists (ASA) Physical Status: Class I-III
  • Surgical Position: Requires the use of either the Trendelenburg position or the Reverse Trendelenburg position during the procedure.
  • Ventilation: Planned mechanical ventilation is required during the procedure, with suitability for one of the following modes: pressure-regulated volume-controlled ventilation (PRVC), conventional volume-controlled ventilation (C-VCV), or pressure-controlled ventilation (PCV).

You may not qualify if:

  • Significant Cardiopulmonary Disease:
  • Intracranial Disease
  • Severe Coagulopathy or Current Anticoagulant Therapy
  • Presence of Psychiatric Illness, Cognitive Impairment, or other condition that precludes the ability to understand or comply with the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inner Mongolia Baogang Hospital

Baotou, Inner Mongolia, 014010, China

Location

MeSH Terms

Interventions

Head-Down Tilt

Intervention Hierarchy (Ancestors)

PostureMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Xiaguang XG Duan, Master's degree

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2025

First Posted

February 3, 2025

Study Start

February 1, 2025

Primary Completion

May 1, 2025

Study Completion

May 10, 2025

Last Updated

February 3, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL
Time Frame
January 2026-January 2036
Access Criteria
A proposal that describes planned analyses must be submitted or whether a data sharing agreement must be signed.

Locations